Navigation Links
Metametrix Announces Acquisition of Accu-Chem Laboratories
Date:1/22/2009

DULUTH, Ga., Jan. 22 /PRNewswire/ -- Metametrix Clinical Laboratory (http://www.metametrix.com), a leader in nutritional and metabolic testing services, announced today their acquisition of Accu-Chem Laboratories.

Accu-Chem Laboratories is well-known for over 24 years of experience in providing clinical, and occupational toxicological testing. The testing performed by Accu-Chem includes analyses of body fluids and tissues for recognized toxic chemicals including chlorinated pesticides, volatile solvents, and polychlorinated biphenyls (PCBs).

"We are excited about the acquisition of Accu-Chem Laboratories," says Dr. J. Alexander Bralley, CEO of Metametrix Clinical Laboratory. "Incorporating Accu-Chem testing into our current test offerings will allow us to offer a broader range of toxicological testing services to our clients, which will in turn help them offer more detailed treatment plans to their patients."

These tests, which will fall under the Toxic Effects Profiles, are beneficial for patients who have been exposed to toxic chemicals from various sources including work environments, toxic spills, and industrial land, air, and water pollutants.

For 25 years, Metametrix Clinical Laboratory has been an industry leader in producing innovative, Next Generation Technologies(SM) for measuring nutritional insufficiencies, metabolic dysfunction, as well as toxic influences on health. Metametrix is committed to applying the latest advances in testing services to functional and integrative medicine with a focus on quality, innovation, and education.

For Information: http://www.metametrix.com


'/>"/>
SOURCE Metametrix Clinical Laboratory
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Metametrix Introduces the New Fat-Soluble Vitamins Profile - A Snapshot of Overall Nutrition
2. Metametrix Introduces the New Neopterin/Biopterin Profile
3. Jenny Craig Inc. Announces New Wellness Campaign: The Great Take-Off
4. EliteMeetings.com Announces Commission-Free Policy Comprehensive Search and RFP Engine Now Provides Net Rates for Groups
5. Hillenbrand, Inc. Announces First-Quarter Earnings Release Date and Conference Call
6. MedX Health Announces Initiation of Laser Acupuncture Study for Controlling Addiction
7. ConvaTec Announces Expanded Indications for AQUACEL(R) and AQUACEL(R) Ag Dressings in Management of Surgical Wounds
8. Mayo Clinic Announces Sharing Mayo Clinic Blog for Patients, Employees
9. Warner Chilcott Announces 2009 Financial Guidance Conference Call
10. Mayo Clinic Announces Sharing Mayo Clinic Blog for Patients, Employees
11. China Medical Technologies Announces the Receipt of SFDA Approval for Two of its FISH Probes and the Approval for the Hi-Tech Enterprise Status for its PRC Subsidiaries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... York, NY (PRWEB) , ... April 29, 2016 , ... New York City based oral ... . This surgery is a very effective way to treat obstructive sleep apnea. Dr. Jamali ... , Orthognathic surgery is a procedure that involves one or both jaw bones. This surgery ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market ... funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... and accelerate its technology and product roadmap. , “Jvion is experiencing ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... print media enterprise focused entirely on patients with cancer, today announced that Lynne ... chosen as the 2016 CURE® Extraordinary Healer® for Oncology Nursing , which ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, ... animal line of probiotics, Petbiotics ™, as they fondly call them. As ... rescue groups networking for their non-profit organizations. Animal rescues across the nation face ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... awareness for Duchenne muscular dystrophy, and funding for Duchenne research, participated in the ... of the Sarepta Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the Marriott ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
(Date:4/28/2016)...  Marking its one year anniversary since launching ... risk test, Color Genomics announced a ... impact the most common hereditary cancers affecting both ... analyzes hereditary cancer risks for breast, colorectal, melanoma, ... Color Test is physician ordered and includes genetic ...
(Date:4/28/2016)... 28, 2016 Dr. Vivek Ahuja ... and Ste phen Schmidt ... leading provider of cloud-based software solutions for life sciences, today announced ... bring a wealth of insight to a growing business.  This will ... George Phillips joined ArisGlobal in the position of ...
Breaking Medicine Technology: